TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells.
Tuthill MH, Montinaro A, Zinngrebe J, Prieske K, Draber P, Prieske S, Newsom-Davis T, von Karstedt S, Graves J, Walczak H.
Tuthill MH, et al. Among authors: walczak h.
Oncogene. 2015 Apr 16;34(16):2138-2144. doi: 10.1038/onc.2014.156. Epub 2014 Jun 9.
Oncogene. 2015.
PMID: 24909167
Free PMC article.